HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame

This article was originally published in The Rose Sheet

Executive Summary

What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm may begin thinning out following a June mistrial and now the reversal of an earlier $72m verdict against the company, both due to jurisdictional issues dictated by a recent Supreme Court ruling.

You may also be interested in...



J&J Appeal Of $2bn Talcum Powder Judgment Denied By US Supreme Court

The Supreme Court said on 1 June that it would not review a $2bn verdict in Missouri for 22 women who alleged links between ovarian cancer and asbestos-tainted talc in Johnson’s Baby Powder. J&J believes the US' top court passed on an "extraordinary opportunity" that "leaves unresolved significant legal questions that state and federal courts will continue to face."

House Committee Hearing Shows How Talc/Asbestos Concerns Could Be Impetus For Cosmetics Reform

“If I were in your shoes or in Commissioner Gottlieb’s shoes I wouldn’t wait another day to require a warning on all [talc-containing cosmetic] products,” EWG’s Scott Faber told a House Oversight and Reform subcommittee March 12, while maintaining that large-scale regulatory changes are what's truly needed to protect users of talcum powders and other personal-care items.

J&J Hopes To Continue Appellate Streak Following Whopping $4.69bn Talc Verdict

Counsel for 22 women who blame J&J talcum powders for their ovarian cancer took a new approach in this latest case in St. Louis Circuit Court, arguing that asbestos in the firm’s talc is the culprit, rather than talc itself. J&J is confident in its ability to overturn the verdict, which it characterized as biased and unfounded.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS121264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel